logo
Plus   Neg
Share
Email

Ambac Financial Reports Q1 Adj. EPS Of $7.22 - Quick Facts

Ambac Financial Group, Inc. (AMBC) reported net income of $305.7 million, or $6.70 per diluted share for the first quarter of 2018. Adjusted earnings in the first quarter of 2018 were $329.8 million, or $7.22 per share. During the first quarter of 2018, net premiums earned were $30.9 million, while net investment income was $110.2 million.

Adjusted Book Value per share increased $7.22 to $31.56 at March 31, 2018 from December 31, 2017.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Moderna said Tuesday that it has reached an agreement with the U.S. to initially supply 100 million doses of its experimental vaccine for COVID-19, mRNA-1273. The U.S. government has awarded up to $1.525 billion for the vaccine. Las Vegas, Nevada-based Mr. Wok Foods has recalled about 200,000 pounds of meat and poultry products for misbranding and undeclared allergens, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The recalled products may contain known allergens such as milk, wheat, soy, peanuts, or oysters. They may also contain MSG, sesame products, or sulfites. The U.S. Food and Drug Administration approved the first oral drug to treat patients two months of age and older with spinal muscular atrophy (SMA) that can be taken at home. Roche subsidiary Genentech's Evrysdi (risdiplam) is also the second FDA-approved drug to treat this rare and often fatal genetic disease affecting muscle strength and movement.
RELATED NEWS
Follow RTT